Noun
A lariat.
Source: Webster's dictionaryFour analysts have issued estimates for Reata Pharmaceuticals’ earnings, with estimates ranging from ($3.85) to ($1.23). Source: Internet
Cantor Fitzgerald raised their price target on Reata Pharmaceuticals from $169.00 to $220.00 in a report on Tuesday, November 10th. Source: Internet
DekaBank Deutsche Girozentrale owned 0.18% of Reata Pharmaceuticals worth $5,560,000 as of its most recent filing with the Securities and Exchange Commission. Source: Internet
Farallon Capital Management LLC grew its holdings in shares of Reata Pharmaceuticals by 6.7% in the second quarter. Source: Internet
Finally, Great West Life Assurance Co. Can acquired a new position in Reata Pharmaceuticals in the 4th quarter valued at $277,000. Source: Internet
Reata is a clinical stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways that regulate cellular metabolism and inflammation. Source: Internet